Unither Pharmaceuticals is a 30-year-old French CDMO and world-leader in sterile unit doses using Blow-Fill-Seal (BFS) technology to produce eye drops, saline solutions, and asthma medications. It has a capacity of 5 billion BFS doses with products sold in over 100 countries. Unither recently introduced Euroject®: an innovative BFS-based device for single dose injection of therapeutics, contributing to greater equity in access to vaccines and ensuring safe vaccine administration, while being user-friendly and cost-effective. It employs more than 2000 people in 8 manufacturing plants and R&D center in France, Brazil, China, and the US. Its turnover in 2022 was €371 million.